Cadila Pharmaceuticals (Ahemdabad) has announced the launching of esomeprazole tablets for the treatment of hyperacidity and drug-induced gastritis under the brand name Esiloc.
As per the statement of the company, “Esiloc will be 50 per cent more economical, thus making it a superior yet affordable choice. It will be made available in 20 mg and 40 mg tablets,”
A proton pump inhibitor, Esomeprazole, works on the luminal surface of gastric parietal cells which results in inhibition of acid secretion. Esomeprazole and provides higher rates of healing of erosive gastro-oesophageal reflux (GERD) and sustained resolution of heartburn in patients.
